Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma
Jie Jane Chen(University of California, San Francisco), Nicolas D. Prionas, A. Patel(Memorial Sloan Kettering Cancer Center), Rita A. Mukhtar(University of California, San Francisco), Yunn‐Yi Chen(University of Vermont), Catherine C. Park(University of California, San Francisco), Iowis Zhu(University of California, San Francisco), Florence Yuen(University of California, San Francisco), Michelle Melisko(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Lisa Singer(University of California, San Francisco)
Cited by 6
Related Papers
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Comprehensive analysis of normal adjacent to tumor transcriptomes
|Nature Communications|2017|663
Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence
|Journal of Clinical Oncology|2000|546
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
|Nature Medicine|2016|539
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
|Circulation|2008|454